JP2009514963A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514963A5
JP2009514963A5 JP2008540128A JP2008540128A JP2009514963A5 JP 2009514963 A5 JP2009514963 A5 JP 2009514963A5 JP 2008540128 A JP2008540128 A JP 2008540128A JP 2008540128 A JP2008540128 A JP 2008540128A JP 2009514963 A5 JP2009514963 A5 JP 2009514963A5
Authority
JP
Japan
Prior art keywords
rosacea
pharmaceutical composition
granulomatous
azithromycin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008540128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514963A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/043339 external-priority patent/WO2007086978A2/en
Publication of JP2009514963A publication Critical patent/JP2009514963A/ja
Publication of JP2009514963A5 publication Critical patent/JP2009514963A5/ja
Pending legal-status Critical Current

Links

JP2008540128A 2005-11-09 2006-11-08 肉芽腫性酒さの治療ためのアジスロマイシン Pending JP2009514963A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73484305P 2005-11-09 2005-11-09
PCT/US2006/043339 WO2007086978A2 (en) 2005-11-09 2006-11-08 Azithromycin for treatment of granulomatous rosacea

Publications (2)

Publication Number Publication Date
JP2009514963A JP2009514963A (ja) 2009-04-09
JP2009514963A5 true JP2009514963A5 (https=) 2009-11-19

Family

ID=38309684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008540128A Pending JP2009514963A (ja) 2005-11-09 2006-11-08 肉芽腫性酒さの治療ためのアジスロマイシン

Country Status (10)

Country Link
US (1) US20070105788A1 (https=)
EP (1) EP1945227A4 (https=)
JP (1) JP2009514963A (https=)
CN (1) CN101304750A (https=)
AU (1) AU2006336612A1 (https=)
BR (1) BRPI0617693A2 (https=)
CA (1) CA2626551A1 (https=)
RU (1) RU2008122964A (https=)
WO (1) WO2007086978A2 (https=)
ZA (1) ZA200804896B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
BRPI0908539B8 (pt) * 2008-02-28 2021-05-25 Scherer Technologies Llc R P processo para a preparação de uma forma sólida rápida de dosagem da dispersão, oral de alprazolam
JP2011527709A (ja) * 2008-07-10 2011-11-04 インスパイアー ファーマシューティカルズ,インコーポレイティド 眼瞼炎の治療方法
EP2393355A4 (en) * 2009-01-23 2012-07-25 Inspire Pharmaceuticals Inc METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN
RU2425682C1 (ru) * 2010-04-28 2011-08-10 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Способ лечения акне средней степени тяжести
WO2012092378A1 (en) * 2010-12-29 2012-07-05 Inspire Pharmaceuticals, Inc. Method for treating blepharitis
AU2012275292B2 (en) 2011-06-28 2015-11-12 Chemo Research, S.L. High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis
WO2014100569A1 (en) * 2012-12-20 2014-06-26 Medicis Pharmaceutical Corporation High dosage topical metronidazole gel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009995A (es) * 2001-05-09 2004-06-30 Univ Michigan Uso de composiciones para tratar rosacea.

Similar Documents

Publication Publication Date Title
JP2013505282A5 (https=)
EP2248519A3 (en) Non-mucoadhesive film dosage forms
EP2331095A4 (en) CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
NZ604029A (en) Methods of treating bladder cancer
BR0308989A (pt) Formulações de claritromicina com biodisponibilidade aperfeiçoada e processo de preparação das mesmas
JP2009514963A5 (https=)
MX2009011900A (es) Curacion de herida diabetica.
Işik et al. Analgesic efficacy of prophylactic gabapentin and lornoxicam in preventing postendodontic pain
WO2009022067A3 (fr) Medicament pour traiter la maladie de parkinson
Mercadante Managing breakthrough pain
WO2009022068A3 (fr) Medicament pour traiter la maladie de parkinson
Gaul et al. Dose can help to achieve effective pain relief for acute mild to moderate pain with over-the-counter paracetamol
Ruoff OTC analgesics vs opioids for pain management.
CN103211982A (zh) 一种治疗三叉神经痛的药物
Sethi et al. Systemic antifungal therapy for cutaneous infections in children
SALARPOUR et al. Effectiveness of various medications on post operative pain of vital teeth after root canal therapy
NO20065657L (no) Filmformet ostriol-inneholdende medikament for oral administrasjon
JP2006508993A5 (https=)
Citrome Inhaled loxapine for agitation
Siu et al. A pilot study on the use of tramadol hydrochloride for pain control in an emergency department
Yanev et al. Pain in obesity is not obesity and pain
Mareeswari et al. The myriad presentations of lichen planus
Grisham et al. Contact hypersensitivity stomatitis in response to Suboxone use: A case report
Conrad et al. Phase 2b study of inhaled MP-376 (Aeroquin, levofloxacin inhalation solution) in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection